Skip to main content

3 Result(s)

within Julius Wehrle Remove this filter Cancer Research Remove this filter

and

  1. Article

    Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

    Sushree S. Sahoo, Victor B. Pastor, Charnise Goodings, Rebecca K. Voss… in Nature Medicine (2021)

    Download PDF (577 KB) View Article

  2. No Access

    Article

    Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

    Germline SAMD9 and SAMD9L mutations (SAMD9/9Lmut) predispose to myelodysplastic syndromes (MDS) with propensity for somatic rescue. In this study, we investigated a clinically annotated pediatric MDS cohort (n = ...

    Sushree S. Sahoo, Victor B. Pastor, Charnise Goodings, Rebecca K. Voss… in Nature Medicine (2021)

  3. No Access

    Chapter

    Ponatinib: A Third-Generation Inhibitor for the Treatment of CML

    The establishment of imatinib as the standard therapy for CML marked the beginning of a new era of treatment. Due to occurring intolerance and resistance against the drug, develo** newer inhibitors was promo...

    Julius Wehrle, Heike L. Pahl, Nikolas von Bubnoff in Small Molecules in Oncology (2014)